Cochleovestibular characteristics were investigated in a Dutch DFNA15 family with a novel POU4F3 mutation, L223P
Methods:
A 4-generation pedigree was constructed of the Dutch family with the novel L223P POU4F3 mutation. Pure tone audiometric data were collected and analyzed cross-sectionally in mutation carriers. Age-related typical audiograms were derived. Vestibular examination was performed in most of the mutation carriers. The results were compared to those obtained from previously identified 884del8 and L289F POU4F3 mutation carriers.
Results:
A novel mutation (L223P) in POU4F3 segregated with hearing impairment in the present family. Audiometric analysis generally showed an early-adult to midlife onset of hearing impairment. High-frequency hearing impairment was observed most frequently. Age-related typical audiograms showed a down-sloping configuration at ages of more than 30 years, with the fastest rate of progression at the high frequencies. Vestibular function tests revealed hypofunction of the vestibular labyrinth in 2 mutation carriers (not statistically significant).
Conclusions:
The clinical features in the present family with a POU4F3 mutation were fairly similar to those in the 2 previously described DFNA15 families, but the level of hearing impairment was milder, and there was no substantial vestibular dysfunction.
MortonNE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci1991;630:16–31.
2.
MehlALThomsonV. The Colorado newborn hearing screening project, 1992–1999: On the threshold of effective population-based universal newborn hearing screening. Pediatrics2002;109:E7.
3.
TorielloHVReardonWGorlinRJ. Hereditary hearing loss and its syndromes. In: Oxford monographs on medical genetics. No. 50. Oxford, England: Oxford University Press, 2004.
4.
RehmHL. Genetics and the genome project. Ear Hear2003;24:270–4.
HuygenPLMPauwRJCremersCWRJ. Audiometric profiles associated with genetic nonsyndromal hearing impairment, a review and phenotype analysis. In: MartiniAStephensDReadAP, eds. Genes, hearing and deafness — From molecular biology to clinical practice. London, England: Informa Healthcare, 2007:185–204.
7.
BischoffAMLCHuygenPLMKempermanMH. Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): An analysis in 74 mutation carriers. Otol Neurotol2005;26:918–25.
8.
TamagawaYIshikawaKIshikawaK. Phenotype of DFNA11: A nonsyndromic hearing loss caused by a myosin VIIA mutation. Laryngoscope2002;112:292–7.
9.
BomSJHKempermanMHDe KokYJ. Progressive cochleovestibular impairment caused by a point mutation in the COCH gene at DFNA9. Laryngoscope1999;109:1525–30.
10.
KempermanMHDe LeenheerEMRHuygenPLM. Audiometric, vestibular, and genetic aspects of a DFNA9 family with a G88E COCH mutation. Otol Neurotol2005;26:926–33.
11.
PauwRJCollinRWJHuygenPLMHoefslootLHKremerHCremersCWRJ. Clinical characteristics of a Dutch DFNA9 family with a novel COCH mutation, G87W. Audiol Neurootol2007;12:77–84.
12.
BischoffAMLCPenningsRJHuygenPLM. Cochleovestibular and ocular features in a Dutch DFNA11 family. Otol Neurotol2006;27:323–31.
13.
Di LevaFD'AdamoPCubellisMV. Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). Audiol Neurootol2006;11:157–64.
14.
BolzHBolzSSSchadeG. Impaired calmodulin binding of myosin-7A causes autosomal dominant hearing loss (DFNA11). Hum Mutat2004;24:274–5.
15.
VahavaOMorellRLynchED. Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science1998;279:1950–4.
16.
FrydmanMVreugdeSNagerisBIWeissSVahavaOAvrahamKB. Clinical characterization of genetic hearing loss caused by a mutation in the POU4F3 transcription factor. Arch Otolaryngol Head Neck Surg2000;126:633–7.
17.
GottfriedIHuygenPLMAvrahamKB. The clinical presentation of DFNA15/POU4F3. In: CremersCWRJSmithRJH, eds. Genetic hearing impairment. Its clinical presentations. Basel, Switzerland: Karger, 2002:92–97.
18.
PauwRJvan DrunenFJCollinRWHuygenPLKremerHCremersCW. Audiometric characteristics of a Dutch family linked to DFNA15 with a novel mutation (p.L289F) in POU4F3. Arch Otolaryngol Head Neck Surg2008;134:294–300.
19.
CollinRWChellappaRPauwRJ. Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect subcellular localization and DNA binding. Hum Mutat2008;29:545–54.
20.
WeissSGottfriedIMayroseI. The DFNA15 deafness mutation affects POU4F3 protein stability, localization, and transcriptional activity. Mol Cell Biol2003;23:7957–64.
21.
HertzanoRMontcouquiolMRashi-ElkelesS. Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene. Hum Mol Genet2004;13:2143–53.
22.
XiangMMakladAPirvolaUFritzschB. Brn3c null mutant mice show long-term, incomplete retention of some afferent inner ear innervation. BMC Neurosci2003;4:2.
23.
XiangMGaoWQHassonTShinJJ. Requirement for Brn-3c in maturation and survival, but not in fate determination of inner ear hair cells. Development1998;125:3935–46.
24.
XiangMGanLLiD. Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A1997;94:9445–50.
25.
ErkmanLMcEvillyRJLuoL. Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature1996;381:603–6.
26.
International Organization for Standardization. ISO 389. Acoustics: Standard reference zero for the calibration of pure tone air conduction audiometers. Geneva, Switzerland: International Organization for Standardization, 1985.
27.
International Organization for Standardization. ISO 8253-1. Acoustics: Audiometric test methods I: Basic pure tone air and bone conduction threshold audiometry. Geneva, Switzerland: International Organization for Standardization, 1989.
28.
International Organization for Standardization. ISO 7029. Acoustics: Threshold of hearing by air conduction as a function of age and sex for otologically normal persons. Geneva, Switzerland: International Organization for Standardization, 1984.
29.
HuygenPLMPenningsRJECremersCWRJ. Characterizing and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiol Med2003;1:37–46.
30.
BomSJHDe LeenheerEMRLemaireFX. Speech recognition scores related to age and degree of hearing impairment in DFNA2/KCNQ4 and DFNA9/COCH. Arch Otolaryngol Head Neck Surg2001;127:1045–8.
31.
De LeenheerEMRHuygenPLMCouckePJAdmiraalRJCvan CampGCremersCWRJ. Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family. Ann Otol Rhinol Laryngol2002;111:267–74.
32.
MarresHAMvan EwijkMHuygenPLM. Inherited nonsyndromic hearing loss. An audiovestibular study in a large family with autosomal dominant progressive hearing loss related to DFNA2. Arch Otolaryngol Head Neck Surg1997;123:573–7.
33.
VerhagenWIMter BruggenJPHuygenPLM. Oculomotor, auditory, and vestibular responses in myotonic dystrophy. Arch Neurol1992;49:954–60.
34.
Van LaerLVan EykenEFransenE. The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment. Hum Mol Genet2008;17:159–69.
35.
HertzanoRDrorAAMontcouquiolM. Lhx3, a LIM domain transcription factor, is regulated by Pou4f3 in the auditory but not in the vestibular system. Eur J Neurosci2007;25:999–1005.
